All relevant data are within the paper.

Introduction {#sec001}
============

Prolonged spaceflights often cause deleterious health problems in humans. A number of spaceflight effects have been extensively studied in the past and reviewed \[[@pone.0135157.ref001]--[@pone.0135157.ref004]\]. Some effects may be explained by well-known physiology; e.g. the lack of gravitational stress on the leg musculature results in a rapid loss of bone and muscle, and the lack of the gravitational vector causes problems related to balance and eye movements \[[@pone.0135157.ref001]\]. It had been shown that annulling of gravity influences the molecular mechanisms of the cells directly \[[@pone.0135157.ref003]\]. Cells exposed to real or simulated microgravity change their gene and protein expression behavior \[[@pone.0135157.ref005]--[@pone.0135157.ref007]\], increase apoptosis \[[@pone.0135157.ref008], [@pone.0135157.ref009]\], retard cell growth \[[@pone.0135157.ref010]\] and alter the cytoskeleton \[[@pone.0135157.ref011]--[@pone.0135157.ref013]\]. Moreover, multicellular aggregates were detected, which resembled the organs from which their cells had been derived \[[@pone.0135157.ref014]\].

In recent years it became apparent that studies on the behavior of cancer cells in space might support cancer research on Earth \[[@pone.0135157.ref015]\]. Now it is of interest to compare the roles of distinct proteins in cellular adaption to changed environmental conditions (microgravity). We characterized various lines of human thyroid cancer cells grown under conditions of real and simulated microgravity with the aim to find possibilities of reducing the cancer cell aggressiveness \[[@pone.0135157.ref016]--[@pone.0135157.ref018]\]. Since experiments under real microgravity i.e. spaceflight possibilities are rare and expensive \[[@pone.0135157.ref016]\], a great part of the studies was performed using devices aiming to simulate microgravity on Earth \[[@pone.0135157.ref003], [@pone.0135157.ref019]\]. However, each device affects the cells not only by preventing sedimentation, but also by characteristics of its operation mode, which include transient hypergravity or vibration \[[@pone.0135157.ref020]\]. Therefore, it was considered that some observations made on cells cultured on a microgravity simulating device may not solely be due to preventing cell sedimentation but also due to device-specific effects \[[@pone.0135157.ref018]\]. Furthermore, we also observed that effects are specific for defined types of the thyroid cell lines \[[@pone.0135157.ref021]\]. In order to investigate the influence of altered gravity on the cellular level, we studied different cancer cells on different devices simulating microgravity according to comparable protocols. Prior to characterization, human thyroid cells FTC-133, ML-1, and HTU-5 were cultured on the Random Positioning Machine (RPM, [Fig 1A](#pone.0135157.g001){ref-type="fig"}) \[[@pone.0135157.ref017]\], but only FTC-133 cells on the RPM and the fast rotating 2D-Clinostat (CLINO, [Fig 1B](#pone.0135157.g001){ref-type="fig"}) \[[@pone.0135157.ref018]\] and in Space \[[@pone.0135157.ref016], [@pone.0135157.ref022], [@pone.0135157.ref023]\]. The experiments revealed several aspects and pointed to cytoskeletal proteins and cytokines as prime targets of microgravity effects \[[@pone.0135157.ref003], [@pone.0135157.ref019], [@pone.0135157.ref022], [@pone.0135157.ref023]\].

![**A**: Random Positioning Machine (RPM) and **B**: 2D-Clinostat.](pone.0135157.g001){#pone.0135157.g001}

In this study we investigated the impact of simulated microgravity using the RPM and the CLINO devices on two human follicular thyroid cancer cell lines (ML-1, RO82-W-1) in a parallel manner either for three (3d) or seven (7d) days, respectively, before selected cytokines and cytoskeletal proteins were quantified. To evaluate the possible role of the cytokines IL-6 and IL-8 for the expression of selected proteins in thyroid cancer cells, we studied the impact of IL-6 and IL-8 application on Ki-67, ß~1~-integrin, talin-1, and beta-actin proteins in adherent ML-1 cells. Moreover, we focused on the role of the cytokines IL-6 and IL-8 in ML-1 and RO82-W-1 spheroid formation using the liquid-overlay technique under 1*g*-conditions \[[@pone.0135157.ref024]\]. Cytokines and cytoskeletal proteins, whose release or expression was altered, respectively, are discussed with respect to their specific roles in thyroid cancer.

Methods {#sec002}
=======

Cell lines {#sec003}
----------

### ML-1 cell line {#sec004}

Monolayers of ML-1 follicular thyroid cancer cells \[[@pone.0135157.ref025]\] were cultured on either the RPM or the clinostat. The ML-1 cell line derived from a recurring tumor of a poorly differentiated follicular thyroid carcinoma (stage pT4) of a 50-year-old woman \[[@pone.0135157.ref025]\]. The cell line has a doubling time of 4 days. The cells take up glucose, secrete thyroglobulin, thyroxine, and triiodothyronine and are tumorigenic in nude mice.

### UCLA RO82-W-1 cell line {#sec005}

The RO82-W-1 cell line was established by Estour *et al*. in 1989 \[[@pone.0135157.ref026]\]. The cell line was purchased from Sigma-Aldrich Chemie (Munich, Germany). This cell line derived from the metastases of a follicular carcinoma in a female patient. Although the primary tumor of RO82-W-1 released thyroglobulin (Tg) into the circulation, the uptake of I131 was less than 2% \[[@pone.0135157.ref026]\]. RO82-W-1 cells are Tg-positive and are also tumorigenic in nude mice \[[@pone.0135157.ref026]\].

Both cell lines were cultivated in RPMI-1640 medium at 37°C and 5% CO~2~. The medium was supplemented with 100 μg/mL streptomycin, 100 U/mL penicillin and 10% FCS (all Biochrom, Berlin, Germany).

Because both malignant human thyroid follicular cell lines had retained the ability to synthesize Tg, they represent valuable models for the study of human follicular carcinomas.

Cell Culture Procedure {#sec006}
======================

24 hours before the experiments, cells of both types were seeded into either slide flasks (Thermo Scientific, Roskilde, Denmark) with a growing area of 9 cm^2^ for the CLINO or into T25 flasks (Sarstedt, Nümbrecht, Germany) with a growing area of 25 cm^2^ for the RPM. The cells for each type of culture flasks were randomized to be cultivated as static ground controls (1*g*-condition) or on one of the devices. Phase contrast images were captured. The morphological pictures for RO82-W-1 cells are given in [Fig 2](#pone.0135157.g002){ref-type="fig"}. CLINO and RPM experiments were performed in individual incubators at 37°C, and ground controls were always kept next to the experiments in the same respective incubator, resting under static 1*g*-conditions. Cells of both types were harvested after 3d days and 7d.

![Phase contrast microscopy of RO82-W-1 cells.\
**A:** Follicular thyroid cancer cells cultured for 3d at static 1*g*. The cells proliferated as 2D monolayer. **B:** RO82-W-1 cells incubated for 3d on the RPM. The arrows show 3D aggregates (multicellular spheroids; MCS). The inserts show swimming 3D spheroids in the supernatant. **C:** MCS formed on the CLINO after 3 days. **D:** RO82-W-1 cells cultured for 7 days on the CLINO. The arrows show 3D spheroids. The insert demonstrates a floating spheroid in the supernatant. **E:** RO82-W-1 cells cultured for 7 days at static 1*g*-conditions grow as well as a confluent monolayer. **F:** 7-day-old MCS formed on the RPM (arrows) could be detected and adherent RO82-W-1 cells.](pone.0135157.g002){#pone.0135157.g002}

Effects of IL-6 and IL-8 on adherent ML-1 cells grown under 1*g*- conditions {#sec007}
----------------------------------------------------------------------------

ML-1 cells from frozen stocks were cultivated in T75 flasks in RPMI 1640 medium until they reached subconfluence (3--5 days). Afterwards the cells were subcultured in 5 T175 and as soon as they reached subconfluence they were subcultured again in 20 T175 flasks. After getting subconfluent, the cells were treated with vehicle RPMI 1640 medium or with 0.03 ng/mL, 1 ng/mL, 10 ng/mL, 100 ng/mL of IL-6 or 1 ng/mL, 10 ng/mL, 45 ng/mL or 100 ng/mL of IL-8 concentrations, respectively \[[@pone.0135157.ref027]--[@pone.0135157.ref029]\]. We also applied for the IL-6 group 0.03 ng/mL and for IL-8 45 ng/mL, because these concentrations were released in the supernatant by ML-1 cells after 7 days.

10 T175 flasks (2 T175 without IL-6 or IL-8 and 8 T175 with different concentrations of IL-6 or IL-8) were cultivated in the incubator (1*g*) for 3d, and another set of 10 T175 for 7d.

After 3d or 7d the medium in the culture flasks has been discarded, the cells were scraped in 10 ml of DPBS and centrifuged by 6000 rpm for 15 minutes. The supernatant was removed, the pellet was dissolved in 1 ml of DPBS and centrifuged again by 6000 rpm for 15 minutes. The pellets were immediately used for protein extraction, Western blot analysis of beta-actin, ß~1~-integrin, talin-1 and Ki-67 and following densitometry \[[@pone.0135157.ref017],[@pone.0135157.ref019]\]. The results are given in [Fig 3](#pone.0135157.g003){ref-type="fig"}.

![Effects of IL-6 and IL-8 on the amount of selected proteins in adherent ML-1 cells grown under normal 1*g*-conditions.\
Western blot analyses and densitometric data are given. **A, C:** beta-actin, 3d and 7d; **B, D:** ß~1~-integrin, 3d and 7d; **E, G:** Ki-67, 3 and 7 days; **F, H**: Talin-1, 3 and 7 days. IL-6 doses: 0.03 ng/mL; 1 ng/mL; 10 ng/mL and 100 ng/mL. The dose 0.03 ng/mL is the maximal amount of IL-6 released by ML-1 cells in the supernatant and measured by MAP (dark-grey columns). IL-8 doses: 1 ng/mL; 10 ng/mL; 45 ng/mL and 100 ng/mL. The dose 45 ng/mL is the maximal amount of IL-8 released by ML-1 cells in the supernatant and measured by MAP (dark-grey columns).](pone.0135157.g003){#pone.0135157.g003}

Liquid-overlay technique {#sec008}
------------------------

Multicellular tumor spheroids were produced with the help of the liquid-overlay technique \[[@pone.0135157.ref024]\]. Thyroid cancer cells of the ML-1 cell line and the UCLA RO82-W-1 cell line harvested from adherently growing confluent monolayers were plated on agarose-coated 96-multiwell test plates (Nunc GmbH, Wiesbaden, Germany) at a concentration of 4000 cells/200 μL RPMI 1640 medium and were incubated at 37°C and 5% CO~2~. The cells were stimulated with vehicle, IL-6 (1 ng/mL, 10 ng/mL and 100 ng/mL) and IL-8 (1 ng/mL, 10 ng/mL and 45 ng/mL). After 3d and 7d pictures were taken and the results presented in [Fig 4](#pone.0135157.g004){ref-type="fig"}.

![Liquid-overlay technique.\
**A1-A7:** Phase contrast microscopic pictures taken after 3d. ML-1 cells grown in agarose-coated wells, treated with vehicle or different doses of IL-6 or IL-8, respectively. **A8:** 3-day-old spheroid and adherent ML-1 cells on the CLINO. **B1-B7:** Photos taken after 3d. RO82-W-1 thyroid cancer cells grown in agarose-coated wells, treated with vehicle or different doses of IL-6 or IL-8, respectively. **B8:** 3-day-old spheroid and adherent RO82-W-1 cells on the CLINO. **C1-C7:** Pictures taken after 7d. ML-1 cells grown in agarose-coated wells, treated with vehicle or different doses of IL-6 or IL-8, respectively. B8: 7-day-old spheroid and adherent ML-1 cell population after incubation in the 2D CLINO. **D1-D7:** Phase contrast images taken after 7d. RO82-W-1 thyroid cancer cells grown in agarose-coated wells, treated with vehicle or different doses of IL-6 or IL-8, respectively. **D8:** 7-day-old MCS and adherent RO82-W-1 cells after culture in the CLINO.](pone.0135157.g004){#pone.0135157.g004}

Random Positioning Machine {#sec009}
--------------------------

The RPM was purchased from ADS, former Dutch Space, Leyden, the Netherlands ([Fig 1A](#pone.0135157.g001){ref-type="fig"}). Its construction and function was described earlier by van Loon \[[@pone.0135157.ref030]\]. It consists of two independent rotating frames within each other. In our experiments, the RPM was operated in "random mode" (60°/s), in which direction is changed continuously and randomly. Over time, the gravity vector of the Earth is nullified. During experiments, the RPM was loaded with up to 15 T25 cm^2^ flasks that were fixed to the ground plate of the machine. In effect, all flasks resided within a distance of 7.5 cm from the center of rotation. In the relatively low speed (60°/s) of the RPM, the centrifugal force experienced by cells even at the furthest points from the center of rotation is assumed to be negligible \[[@pone.0135157.ref030]\].

2D Clinostat {#sec010}
------------

The 2D CLINO device (manufactured by DLR, Cologne, Germany, [Fig 1B](#pone.0135157.g001){ref-type="fig"}) consists of six arms enabling the rotation of the samples around an axis perpendicular to the force of gravity \[[@pone.0135157.ref031]\]. Each rotating arm was loaded with 4 slide flasks, for a total of 24 flasks per run. On the CLINO, the gravity vector is randomized by fast and constant rotation. Great care was taken to ensure that all flasks selected for clinorotation were free of air bubbles that would otherwise induce chaotic fluid movement. The 2D CLINO rotating constantly at 60 rpm generates residual accelerations within the distance of 3 mm around the center of rotation in the order of 0.012*g*, while cells located at further distance experience up to 0.036*g* \[[@pone.0135157.ref018], [@pone.0135157.ref031]\]. Although the gravity-related threshold of thyroid cancer cells is unknown, only the cells located within the distance of 3 mm around the rotational axis were harvested for the analyses, meaning that these cells had experienced a very low residual acceleration.

pH measurements {#sec011}
---------------

The pH was measured with a Metrohm 827 pH-meter no more than 1 hour after experiment termination. All measurements were performed twice, and the samples were kept in closed Eppendorf tubes until measurement to avoid reactions with atmospheric gases.

Phase contrast microscopy {#sec012}
-------------------------

The Axiovert 25 Microscope (Carl Zeiss Microscopy, LLC, USA) was used for visual observation of the morphology of the cells.

Western blot analyses {#sec013}
---------------------

Western blot analyses, immunoblotting, and densitometry were performed according to routine protocols \[[@pone.0135157.ref032]--[@pone.0135157.ref037]\]. The following antibodies were used to quantify the antigens: Anti-beta-actin, and anti-talin-1 were used at a dilution of 1:1000 (Cell Signaling Technology, Inc., Danvers, MA, USA); as well as anti-integrin-beta~1~ antibody (Epitomics, Burlingame, USA); Ki-67 was purchased from Santa Cruz Biotechnology, Santa Cruz, TX, USA (dilution 1:500); the secondary, HRP-linked antibody was utilized at a dilution of 1:4000 (Cell Signaling Technology, Inc., Danvers, MA, USA). As a loading control glyceraldehyde 3-phosphate dehydrogenase (ABR-Affinity BioReagents, Golden, USA; dilution: 1:10 000) was used.

The membranes were analyzed using ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA; <http://rsb.info.nih.gov/ij/>), for densitrometric quantification of the bands.

F-actin staining {#sec014}
----------------

F-actin was visualized by rhodamine-phalloidin staining (Molecular Probes, Eugene, OR, USA) and the nuclei were stained with Hoechst 33342 (Molecular Probes, Eugene, OR, USA), as published earlier \[[@pone.0135157.ref036], [@pone.0135157.ref037]\]. The samples were mounted with Vectashield (Vector, Burlingame, CA, USA) and analyzed microscopically. The F-actin stained samples were examined using a Zeiss 510 META inverted confocal laser scanning microscope (Zeiss, Germany), equipped with a Plan-Apochromat 63×1.4 objective. Excitation and emission wavelengths were: λexc = 488 nm and λem = ≥505 nm for FITC. Afterwards, the samples were analyzed with the help of the image analysis program Scion Image (Version 1.63 MacOs, Scion Corporation, USA).

Cytokine measurements by Multi-Analyte Profiling technology {#sec015}
-----------------------------------------------------------

The release of cytokines was investigated via Multi-Analyte Profiling (MAP) as previously described \[[@pone.0135157.ref018], [@pone.0135157.ref022]\]. For each condition, five supernatants were collected after 72 h and stored at -80°C until testing. The MAP was carried out by the company Myriad RBM (Austin, Texas, USA), they determined the Human Cytokines of the selections MAP A and B.

Cytokine measurement by Enzyme Linked Immunosorbent Assay {#sec016}
---------------------------------------------------------

IL-6, IL-8, and MCP-1 proteins released from RO82-W-1 cells in the cell culture supernatants during RPM and CLINO experiments were detected by ELISAs purchased from R&D systems \[[@pone.0135157.ref038]\]. The ELISAs have been performed according to the protocols supplied by the manufacturer.

Statistical Evaluation {#sec017}
----------------------

SPSS 15.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical evaluation. The Mann-Whitney-U-Test was performed to compare 1 g and s-μg conditions, as well as s-μg adherent cells and s-μg MCTS cells. All data is presented as mean ± standard deviation (SD). Values of p \< 0.05 were considered significant.

Results {#sec018}
=======

The cells of the follicular thyroid cancer cell lines ML-1 and RO82-W-1 were cultivated for 3d and 7d on the RPM, on the 2D CLINO, and under normal static laboratory 1*g*-conditions. Up to the seventh day, the pH remained in the normal range, irrespective of whether the cells were cultured on the RPM, under 1*g* or on the CLINO. However, the cells remained growing in a monolayer only if culturing was performed under 1*g*, while, when cultured under altered gravity conditions, the cells split into two populations of which one comprised cells remaining adherently, while the other contained cells forming 3D aggregates similar to those described for the FTC-133 cells \[[@pone.0135157.ref018]\].

We received similar results with the RO82-W-1 and ML-1 cells. Both types of cells proliferated like the RO82-W-1 cells shown in [Fig 2](#pone.0135157.g002){ref-type="fig"} as an adherent monolayer ([Fig 2A and 2E](#pone.0135157.g002){ref-type="fig"}) and as multicellular spheroids on the RPM ([Fig 2B and 2F](#pone.0135157.g002){ref-type="fig"}) and the CLINO ([Fig 2C and 2D](#pone.0135157.g002){ref-type="fig"}). There were no differences in terms of number of spheroids of each cell line that arose on either the RPM or the CLINO. Both devices delivered spheroids of different sizes (max. diameter 0.4 mm) at both time points as shown in [Fig 2B, 2C, 2D and 2F](#pone.0135157.g002){ref-type="fig"}. Detachment of AD cells started early and cell detachment and spheroid formation occurred also after 7d.

Impact of IL-6 and IL-8 on ML-1 cells grown under 1*g*-conditions {#sec019}
-----------------------------------------------------------------

IL-6 (0.03 ng/mL and 1 ng/mL) stimulation increased the amount of beta-actin and ß~1~-integrin protein in adherent ML-1 cells. Moreover, IL-8 (1, 10 and 45 ng/mL) increased the beta-actin protein content in these cells, whereas only higher doses (10--100 ng/mL) elevated the protein content of ß~1~-integrin within 3 days ([Fig 3A and 3B](#pone.0135157.g003){ref-type="fig"}).

After 7d, an increase was found for beta-actin protein in all IL-6-treated samples as well as in samples treated with 1 and 10 ng/mL IL-8 ([Fig 3C](#pone.0135157.g003){ref-type="fig"}). The ß~1~-integrin protein was induced by 0.03 ng/mL as well as by 10 ng/mL IL-6, whereas only 10 ng/mL IL-8 induced the amount of the protein after a 7-day-stimulation ([Fig 3D](#pone.0135157.g003){ref-type="fig"}).

In addition, both cytokines (IL-6 and IL-8, all doses) induced an elevation of the Ki-67 protein content after 3d ([Fig 3E](#pone.0135157.g003){ref-type="fig"}). After 7d, all IL-6 doses as well as 1 ng/mL and 100 ng/mL IL-8 increased the amount of Ki-67 protein in ML-1 cells ([Fig 3G](#pone.0135157.g003){ref-type="fig"}). In contrast, the talin-1 protein content was clearly reduced by IL-6 and IL-8 application to the medium. Low doses of IL-6 and all doses of IL-8 were effective ([Fig 3F](#pone.0135157.g003){ref-type="fig"}) during the 3-day-1*g*-experiment. Another result was found after 7d. IL-6 stimulation resulted in an increase of talin-1 ([Fig 3H](#pone.0135157.g003){ref-type="fig"}). A similar finding was seen in IL-8-treated samples (1, 10 and 45 ng/mL) of the ML-1 cell line.

These experiments defined firstly, the optimal IL-6 and IL-8 doses for the expression of distinct proteins under 1*g*-conditions and secondly, the doses to test their impact on MCS formation using the liquid-overlay method (see below and [Fig 4](#pone.0135157.g004){ref-type="fig"}).

Impact of IL-6 and IL-8 on spheroid formation under 1*g*-conditions {#sec020}
-------------------------------------------------------------------

After 3d, ML-1 cells only showed loose cell aggregates, when cultured under 1*g*-conditions on agarose. 10 and 100 ng/mL IL-6 and 1, 10 and 45 ng/mL IL-8 treatment resulted in a better aggregation of the ML-1 cells to spheroids, when they are cultured in the agarose-coated wells (Liquid-overlay technique) ([Fig 4A1--4A7](#pone.0135157.g004){ref-type="fig"}). RO82-W-1 cells formed large irregular aggregates after a 3-day-incubation in agarose-coated wells. Both cytokines improved the formation of RO82-W-1 multicellular spheroids using the liquid-overlay method ([Fig 4B1--4B7](#pone.0135157.g004){ref-type="fig"}).

After 7d, ML-1 cells showed irregular formed cellular aggregates on agarose. The cytokine-treated groups contained several dense spheroids after one week of stimulation ([Fig 4C](#pone.0135157.g004){ref-type="fig"}). The ML-1 spheroids formed on the CLINO were similar to the liquid-overlay spheroids treated with 45 ng/mL IL-8 ([Fig 4C7 and 4C8](#pone.0135157.g004){ref-type="fig"}).

After 7d, the RO82-W-1 cells grew in form of dense multicellular spheroids as well as single cells swimming in the supernatant in agarose-coated wells. Cytokine application to the medium enhanced slightly the size of the spheroids ([Fig 4D1--4D7](#pone.0135157.g004){ref-type="fig"}).

The spheroids of both cell types formed after IL-6 and IL-8 treatment exhibited a similar morphology than the MCS produced after incubation on the CLINO ([Fig 4A8, 4B8, 4C8 and 4D8](#pone.0135157.g004){ref-type="fig"}).

Cytokine release by ML-1 cells {#sec021}
------------------------------

Measuring the cytokines of the Human Cytokine selections MAP A and B we detected IL-4, IL-6, IL-7, IL-8, IL-17, MCP-1, VEGF-A and eotaxin-1 in the supernatants of the various cell cultures. We measured about 32 pg/mL IL-4 and IL-7 in the supernatants of 3-day-old cell cultures, irrespective of whether the cells had been incubated on the RPM, on the CLINO or in the stationary 1*g*-control. After a 7-day-exposure, the cell culture supernatants contained around 47 pg/mL IL-4 and about 43 pg/mL Il-7, independently of the culture conditions ([Fig 5A and 5C](#pone.0135157.g005){ref-type="fig"}). A similar phenomenon was observed with respect to IL-8 and VEGF-A. About 710 pg/mL VEGF-A and 11,000 pg/mL IL-8 were found in the supernatants of 3-day-old cultures, irrespective of whether the cells had been incubated on the RPM, on the CLINO or under stationary 1*g*-conditions. After a 7-day-exposure, VEGF-A and IL-8 concentrations were enhanced to around 3000 pg/mL VEGF-A and about 35,000 pg/mL Il-8 were detected, again without significant difference with respect to culturing conditions ([Fig 5D and 5F](#pone.0135157.g005){ref-type="fig"}). Taken together, [Fig 5A, 5C, 5D and 5F](#pone.0135157.g005){ref-type="fig"} show that the content of IL-4, IL-7, VEGF-A and IL-8 in the culture supernatants were enhanced in the 7-day-samples as compared to the 3-day-samples, while a significant influence of exposing cells to the RPM or the CLINO could not be seen for these 4 types of cytokines.

![**A**: IL-4, **B**: IL-6, **C**: IL-7, **D**: IL-8, **E**: MCP-1, **F**: VEGF-A proteins released by ML-1 cells into the supernatant after a 3- and 7-day-exposure to the RPM or the 2D Clinostat, determined by Multi-Analyte Profiling of the supernatant. RPM: Random Positioning Machine; CLINO: 2D Clinostat; \*p\<0.05](pone.0135157.g005){#pone.0135157.g005}

In contrast, the accumulation of IL-6 and MCP-1 in the different culture supernatants clearly depended on the culture conditions. A release of 27 and 33 pg/mL IL-6 was found in the supernatants of RPM samples after 3d and 7d of culturing, respectively, while an amount of 22.5 pg/mL IL-6 was measured in relevant 1*g*-controls ([Fig 5B](#pone.0135157.g005){ref-type="fig"}). Similarly, a concentration of 24 and 36 pg/mL IL-6 was found in the supernatants of CLINO samples after a 3- and 7-day-experiment, respectively, while about an amount of 25 pg/mL IL-6 was measured in relevant 1*g*-controls ([Fig 5B](#pone.0135157.g005){ref-type="fig"}). In addition, the monocyte chemoattractant protein-1 (MCP-1) levels changed, when cell culturing was performed on devices simulating microgravity. Under normal gravity conditions, about 600 pg/mL MCP-1 were found after 3 days and between 700 and 750 pg/mL after 7 days, while MCP-1 concentrations increased from 750 to 950 pg/mL on the RPM and from 700 to 1000 pg/mL on the CLINO ([Fig 5E](#pone.0135157.g005){ref-type="fig"}).

In addition to the six cytokines shown in [Fig 5](#pone.0135157.g005){ref-type="fig"} we searched for further cytokines as shown in [Table 1](#pone.0135157.t001){ref-type="table"}. However, we did not detect further cytokines released into the supernatant during 3 days of cell culturing under any condition. Release of IL-17 and eotaxin was detectable in samples cultured for 7 days on the CLINO, on the RPM as well as on the ground with no significant differences at concentrations of around 1 pg/mL (IL-17) and 15 pg/mL (eotaxin) ([Table 1](#pone.0135157.t001){ref-type="table"}).

10.1371/journal.pone.0135157.t001

###### Soluble factors secreted by ML-1 cells.

![](pone.0135157.t001){#pone.0135157.t001g}

                                Factor       LDD                     Random Positioning Machine   Clinorotation                                                            
  ----------------------------- ------------ ----------- ----------- ---------------------------- --------------- ------------- ------ ------ ------------- -------------- ------
  **Human CytokineMAP A 1.0**   **GM-CSF**   2,9         \[pg/ml\]   n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           n.d.
  **IFN-γ**                     0,32         \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-2**                      1,2          \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-3**                      0,00032      \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-5**                      0,55         \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-10**                     0,66         \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-18**                     1,3          \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **MIP-1α**                    3,6          \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **MIP-1β**                    3,2          \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **TNF-α**                     2,6          \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **TNF-β**                     0,6          \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **Human CytokineMAP B 1.0**   **BDNF**     0,0054      \[ng/ml\]   n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           n.d.
  **Eotaxin-1**                 13           \[pg/ml\]   n.d.        n.d.                         13.4 ± 7.9      17.6 ± 2.3    n.d.   n.d.   16.4 ± 1.8    13.6 ± 7.8     
  **ICAM-1**                    0,65         \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-1α**                     0,0003       \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-1β**                     0,44         \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-1ra**                    31           \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-12p40**                  0,019        \[ng/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-12p70**                  6,8          \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-15**                     0,039        \[ng/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **IL-17**                     0,31         \[pg/ml\]   n.d.        n.d.                         1.078 ± 0.229   1.2 ± 0,071   n.d.   n.d.   1.12 ± 0.16   1.02 ± 0.602   
  **IL-23**                     0,13         \[ng/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **MMP-3**                     0,0052       \[ng/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
  **SCF**                       13           \[pg/ml\]   n.d.        n.d.                         n.d.            n.d.          n.d.   n.d.   n.d.          n.d.           
                                                                                                                                                                           

Values are given with mean ± SD; 1*g*, corresponding ground control; n.d., not detectable; LDD (Least Detectable Dose)-determined as the mean ± 3 standard deviations of 20 blank readings.

Cytokine release by RO82-W-1 cells {#sec022}
----------------------------------

We investigated the release of selected cytokines in the supernatant of RO82-W-1 cells after a 3-day-exposure to the RPM or the CLINO devices. The amount of IL-6 was significantly elevated from 56.9 pg/mL to 75.2 pg/mL on the RPM ([Fig 6A](#pone.0135157.g006){ref-type="fig"}). A similar result was obtained for IL-8 ([Fig 6B](#pone.0135157.g006){ref-type="fig"}). Non-significant increases for both cytokines were measured for the CLINO-samples.

The secretion of MCP-1 of RO82-W-1 cells was much lower than the release of ML-1 cells (Figs [5E](#pone.0135157.g005){ref-type="fig"} and [6C](#pone.0135157.g006){ref-type="fig"}). Culture of RO82-W-1 cells on the RPM or the CLINO completely blunted the release of MCP-1 ([Fig 6C](#pone.0135157.g006){ref-type="fig"}).

![**A:** IL-6, **B:** IL-8, and **C:** MCP-1 proteins released by RO82-W-1 thyroid cancer cells into the supernatant after a 3-day-exposure to the RPM or the 2D CLINO, determined by ELISA technique. RPM: Random Positioning Machine; CLINO: 2D Clinostat; \*p\<0.05.](pone.0135157.g006){#pone.0135157.g006}

Effects of simulated microgravity on the cytoskeleton {#sec023}
-----------------------------------------------------

Since earlier studies have shown that cytoskeletal proteins of different types of cells are severely affected by microgravity \[[@pone.0135157.ref011]--[@pone.0135157.ref013], [@pone.0135157.ref037], [@pone.0135157.ref039]--[@pone.0135157.ref041]\], we performed F-actin staining on cells cultured on the RPM and on the 2D CLINO for 3d and 7d. After 3 days, an accumulation of F-actin along the outer cellular membrane was visible in ML-1 cells as well as in RO82-W-1 cells cultured on the CLINO and the RPM ([Fig 7](#pone.0135157.g007){ref-type="fig"}). After 7 days, the cells were completely confluent and overgrew each other. A thickening of the outer membrane was found under both conditions (1*g* and simulated microgravity), but was more pronounced on the RPM and the CLINO.

![F-Actin staining of ML-1 and RO82-W-1 cells after 3d and 7d on the RPM and on the CLINO.\
**A-C:** ML-1 3-day-experiment. **A:** ML-1 cells, 3d, 1*g*-condition: normal cells with normal F-actin cytoskeleton **B:** ML-1 cells, 3d, accumulation of F-actin at the outer cellular membrane (yellow arrows) after RPM-exposure. The white arrow marks the detaching of cell aggregates from the adherent cell layer. **C:** ML-1 cells, 3d, thicker layers of F-actin at the outer cellular membrane (yellow arrows). **D-F:** ML-1 7-day-experiment. **D:** ML-1 cells, 7d, 1*g*-condition: confluent normal cells with normal F-actin cytoskeleton. **E:** ML-1 cells cultured on the RPM for 7d revealed thicker layers of F-actin at the outer membrane (insert). **F:** A 7-day-exposure of ML-1 cells to the CLINO induced similar changes of the F-actin cytoskeleton. The insert shows ticker F-actin fibers at the cellular membranes. **G-I:** RO82-W-1 3-day-experiment. **G:** normal F-actin cytoskeleton of RO82-W-1 cells. **H:** MCS formation (yellow arrows) after a 3-day-incubation on the RPM. An accumulation of F-actin at the outer cellular membrane is visible (yellow arrows). **I:** RO82-W-1 cultured for 3d on the clinostat revealed a clear thickening of the F-actin fibers (arrows). Insert: 3D MCS. **J-L**: RO82-W-1 7-day-experiment. **J:** F-actin cytoskeleton of confluent RO82-W-1 cells grown at 1*g*. **K, L:** MCS formation of RO82-W-1 cells after RPM- (**K**) and CLINO-exposure (**L**). The arrows indicate the 3D MCS and a thickening of F-actin fibers at the outer membranes.](pone.0135157.g007){#pone.0135157.g007}

Western blot analyses of β-actin in ML-1 cells revealed a decrease after 7d of clinorotation ([Fig 8A](#pone.0135157.g008){ref-type="fig"}), but the protein remained unchanged after 7d of RPM-exposure. Exposure of the ML-1 cells to the RPM and clinostat induced significant decreases of β~1~-integrin in AD and MCS cells after 7d ([Fig 8B](#pone.0135157.g008){ref-type="fig"}). Talin-1 protein was significantly reduced in AD cells only, when the ML-1 cells were incubated on the CLINO ([Fig 8C](#pone.0135157.g008){ref-type="fig"}). Ki-67 protein, a nuclear protein~~,~~ associated with the cellular proliferation process, was significantly elevated in AD cells compared with MCS and 1*g*-control cells on both devices ([Fig 8D](#pone.0135157.g008){ref-type="fig"}).

![Western blot analyses of **A-D:** ML-1 cells after a 7-day-exposure on the RPM and CLINO. **A**: ß-actin, **B**: ß~1~-integrin, **C**: talin-1 and **D:** Ki-67 proteins. Clear differences between the two devices are found for ß-actin. Western blot analyses of **E-H:** RO82-W-1 cells after a 7-day-exposure on the RPM and CLINO. **E:** ß-actin, **F:** ß~1~-integrin, **G:** talin-1 and **H:** Ki-67 proteins. There was no change in the beta-actin content of RO82-W-1 cells cultured on the RPM or the CLINO for 7d. The amount of ß~1~-integrin and Ki-67 was comparable to the ML-1 cultures grown under s-μ*g*. \*P\<0.05.](pone.0135157.g008){#pone.0135157.g008}

No change in beta-actin was found in RO82-W-1 cells after a 7-day-culture on the RPM or the CLINO ([Fig 8E](#pone.0135157.g008){ref-type="fig"}). The protein content of beta-actin remained constant. The protein contents of beta~1~-integrin, talin-1 and Ki-67 of RO82-W-1 cells were comparable to those of the ML-1 cell line, irrespective of culture conditions ([Fig 8F--8H](#pone.0135157.g008){ref-type="fig"}).

Discussion {#sec024}
==========

Ground-based facilities such as the RPM and the CLINO, used to simulate conditions of microgravity on Earth, have various benefits. They are important tools to prepare a future space mission \[[@pone.0135157.ref003], [@pone.0135157.ref004], [@pone.0135157.ref007], [@pone.0135157.ref030], [@pone.0135157.ref039]--[@pone.0135157.ref042]\]. They allow us also to explore altered gravity (microgravity)--related effects on Earth. However, most often they show superimposing effects, which may be due to the characteristics of a device. Common effects exerted by the RPM and the CLINO on target cells of interest may be induced due to prevention of sedimentations. We have recently demonstrated that the CLINO and the RPM are suitable to trigger FTC-133 cells to develop MCS and to decrease expression of CAV1 and CTGF genes in MCS \[[@pone.0135157.ref018]\]. In this study we focused on the regulation of cytokines and cytoskeletal proteins of two follicular thyroid cancer cell lines ML-1 and RO82-W-1 under the influence of the devices. In Ml-1 cells, we observed an enhanced release of IL-6 and MCP-1, an elevated Ki-67 protein content in AD cells, but a reduced production of ß~1~-integrin and talin-1 in AD cells. RO82-W-1 cells exhibited a similar production of these proteins, when the cells were exposed to simulated microgravity conditions. The release of IL-6 and IL-8 was enhanced in RO82-W-1 cells, but MCP-1 secretion was blunted under conditions of microgravity. Different reactions of the two cell lines under CLINO- or RPM-exposure might be due to their different origin and characteristics.

Since both machines trigger similar cytoskeletal changes in both cell lines, we concluded that these alterations might be important in adaptation to microgravity \[[@pone.0135157.ref004], [@pone.0135157.ref011]--[@pone.0135157.ref013], [@pone.0135157.ref036], [@pone.0135157.ref037]\]. Furthermore, the proteins investigated play also a role in cancer development and progression.

A number of cytokines are known to play a role in tumor cell proliferation, apoptosis, and angiogenesis \[[@pone.0135157.ref043]\]. IL-4 has been described as a growth factor of thyroid cancer cells. It promotes resistance to chemotherapy by upregulating secondary messengers \[[@pone.0135157.ref044]\]. The role of IL-7 in relation to thyroid cancer remains largely unknown. Increased serum levels of IL-7 in conjunction with IL-6, IL-10 and IL-14 had been shown to indicate both benign and malignant thyroid disease \[[@pone.0135157.ref045]\]. IL-8 plays a role in arthroid disease \[[@pone.0135157.ref046]\]. In addition, IL-8 is responsible to tumor progression and liver metastasis of colorectal tumors \[[@pone.0135157.ref047]\]. IL-17 plays a role in tumor development, but the mechanisms of IL17 involvement are still uncharacterized \[[@pone.0135157.ref048]\]. Also VEGF promotes neoangiogenesis. It is produced by many thyroid cancer cells and supports infiltration of thyroid tumors by vasculature and thus promotes tumor growth \[[@pone.0135157.ref049], [@pone.0135157.ref050]\]. Its neutralization by antibodies or drugs is currently of great interest in tumor therapy \[[@pone.0135157.ref051], [@pone.0135157.ref052]\]. All these cytokines were accumulated in supernatants of ML-1 cultures progressively during time, while a number of other cancer cell-related cytokines could not be detected in the various supernatants ([Table 1](#pone.0135157.t001){ref-type="table"}). There was no gravity-dependent influence on the secretion of the various cytokines by ML-1 cells mentioned in [Table 1](#pone.0135157.t001){ref-type="table"} and of those described above besides slight differences found for IL-7 and IL-8 ([Fig 5](#pone.0135157.g005){ref-type="fig"}). Hence, we concluded that a number of cytokines, playing a role in tumor development are not affected by culturing the cells on the devices applied. It is of interest that also the amounts of VEGF-A and eotaxin in the supernatants of the FTC-133 cells cultured during the Shenzhou-8 flight in real microgravity and on 1*g*-reference centrifuge were equal, respectively \[[@pone.0135157.ref022]\].

The up-regulation of IL-6 and MCP-1 occurred in RPM and CLINO samples of the ML-1 cell line ([Fig 5B and 5E](#pone.0135157.g005){ref-type="fig"}). IL-6, along with IL-8, had already been suggested to play a role in gravity-sensitive signaling required for spheroid formation \[[@pone.0135157.ref019]\]. To investigate the role of IL-6 and IL-8 on spheroid formation under 1*g*-conditions, we used the liquid-overlay technique \[[@pone.0135157.ref024]\]. We could show for the first time that both cytokines improve 3D aggregation of both ML-1 and RO-82-W-1 cells, which were cultured on agarose-coated wells for 3d and 7d ([Fig 4](#pone.0135157.g004){ref-type="fig"}). The 3- and 7-day-old MCS were comparable to the spheroids grown under conditions of simulated microgravity. In addition, we demonstrated that both cytokines induced the protein expression of beta-actin, beta~1~-integrin, talin-1 and Ki-67 within 3 and 7 days ([Fig 3](#pone.0135157.g003){ref-type="fig"}). These results support recent research suggesting that IL-6 might be an important factor in tumor cell growth, metastasis and angiogenesis \[[@pone.0135157.ref053]\]. Immunohistochemical staining of papillary thyroid tumor samples indicated that MCP-1 expression correlated with an aggressive behavior of this tumor \[[@pone.0135157.ref054]\]. MCP-1 was highly secreted and elevated in ML-1 cells cultured under simulated microgravity. This cell line derived from a poorly differentiated follicular thyroid carcinoma. In contrast, RO82-W-1 cells exhibited a low secretion rate of this cytokine. A 3-day-incubation on the RPM and CLINO blunted the secretion of MCP-1 ([Fig 6C](#pone.0135157.g006){ref-type="fig"}). In space during the Shenzhou-8 mission, we also had measured after 10 days in FTC-133 supernatants 8pg/mL MCP-1 in spaceflight 1g-samples and 6.15 pg/mL MCP-1 in real μg-samples \[[@pone.0135157.ref022]\]. This reduction is in accordance with the results obtained from RO82-W1 samples, which also exhibited a reduction for this cytokine.

In addition, we investigated the F-actin cytoskeleton of the thyroid cancer cells. F-actin accumulated at the outer cellular membranes in both types of follicular thyroid cancer cells cultured on both devices for 3d and 7d ([Fig 7](#pone.0135157.g007){ref-type="fig"}), corresponding to our earlier studies on endothelial cells and human chondrocytes \[[@pone.0135157.ref004], [@pone.0135157.ref036], [@pone.0135157.ref037], [@pone.0135157.ref040]\] and further proves cytoskeletal alterations in cells cultured under microgravity conditions as reported by several authors \[[@pone.0135157.ref011]--[@pone.0135157.ref013], [@pone.0135157.ref055]--[@pone.0135157.ref057]\]. It is well known that microgravity induces changes in the actin cytoskeleton, which is connected to several membrane proteins with impact on cellular polarity, adhesion, migration, and may respond to extracellular signals \[[@pone.0135157.ref055]\]. These alterations occur very early. After the first microgravity phase of a DLR Parabolic Flight a clear rearrangement of the F-actin network with perinuclear clustering was demonstrated in ML-1 cells \[[@pone.0135157.ref055]\]. In addition, MCS formation occurred after 3d and 7d, a thick F-actin layer is visible at the outer membrane of the developing spheroids ([Fig 7K and 7L](#pone.0135157.g007){ref-type="fig"}).

Furthermore, we found a significant reduction of β-actin in CLINO-samples of the ML-1 cell line, whereas, a 7-day-RPM-exposure did not alter the expression of the protein ([Fig 8A](#pone.0135157.g008){ref-type="fig"}). Interestingly, RO82-W-1 cells exhibited no change in β-actin after a 7-day-culture on the RPM and the CLINO ([Fig 8E](#pone.0135157.g008){ref-type="fig"}). This protein is one of two non-muscular cytoskeletal actin types and is important for the stability of cells as well as for motility and structure. β-actin is expressed by tumor cells as well as by healthy cells, and overexpression of β-actin had been found to be associated to metastasis of gastric cancer \[[@pone.0135157.ref058]\], however, its role in thyroid cancer cells is currently unknown. The finding that β-actin is not changed in RO82-W-1 cells and the differences found for CLINO- and RPM-ML1 samples may be explained as follows: The notable differences between the amounts of β-actin on the RPM vs. the clinostat could be firstly, due to patient-specific properties of the two cell lines. Secondly, they may occur because of device characteristic reasons. The RPM consists of two independently rotating frames enabling a 3D rotation with random speed and random direction of the samples aiming to alter the influence of the gravity vector \[[@pone.0135157.ref030]\]. This might induce stress experienced by cells on the RPM when the direction is changed, where cells will experience numerous brakes for changing the vector and for inducing gravitational unloading may be also one possible reason for the difference. ML-1 cells may be more sensitive and can stabilize their cytoskeleton by producing more β-actin on the RPM \[[@pone.0135157.ref007], [@pone.0135157.ref030]\]. This does not occur in the CLINO due to constant rotating with respect to speed and direction. Moreover, on the CLINO, sedimentation is prevented by a fast and constant rotation of the samples around one horizontal axis, assuming that the sample does no longer perceive the gravity stimulus.

Both cell lines exhibit MCS formation on both devices. During MCS formation considerable alterations of various cellular molecules can occur. Some of them might not be directly related to the process of 3D cell aggregation, but by products generated by device-dependent modifications \[[@pone.0135157.ref059]\]. Examples are physical stimuli due to vibration, shearing forces, etc. generated by the simulators \[[@pone.0135157.ref018]\]. The CLINO device rotates constantly at 60 rpm and generates residual accelerations below 0.012*g* within the distance of ±3 mm around the culture flask center \[[@pone.0135157.ref031]\]. Cells located at further distance from the rotation axis are exposed to accelerations reaching up to 0.036 g at about ±9 mm \[[@pone.0135157.ref018]\]. Eiermann *et al*. had demonstrated significant differences in several genes in a human 1F6 melanoma cell line within these acceleration intervals \[[@pone.0135157.ref031]\]. To be sure to keep residual acceleration low, we only collected cells within the central 6 mm (≤ 0.012 g) of a slide flask were collected and analyzed by Western blot analysis in the present study. Such a procedure is not possible for supernatants, and therefore IL-6 and IL-8 as well as all other soluble factors produced by cells from the periphery have a significant influence on cells growing in the center of the slide flasks. This may be one reason for the differences in beta-actin and also talin-1 protein expression. Most importantly, research in simulated microgravity has to be confirmed by a real space experiment.

β~1~-integrin belongs to a family of adhesion molecules and is known to be important in binding the basal membrane and release proteases, thus facilitating the invasion of cancer cells into the surrounding tissue. Follicular as well as papillary thyroid carcinoma cells express increased levels of β~1~-integrin \[[@pone.0135157.ref060], [@pone.0135157.ref061]\]. Talin is a high-molecular weight cytoskeletal protein, which links integrins to the actin cytoskeleton \[[@pone.0135157.ref062]\]. Its overexpression enhanced prostate cancer cell adhesion, migration, and invasion \[[@pone.0135157.ref063]\]. β~1~-integrin and talin-1 are reduced in adherent ML-1 cells. MCS cells of both cell lines contain a lower amount of β~1~-integrin, whereas talin-1 is not significantly changed in MCS as compared with 1*g*-samples, irrespective of the used microgravity simulator ([Fig 8](#pone.0135157.g008){ref-type="fig"}). The protein content of talin-1 in RO82-W-1 MCS is higher than in AD cells on both devices. The differences between the RPM and CLINO devices as already discussed may be the reason for this finding. In an earlier study we had already investigated ML-1 cells for 72 h on a 3D clinostat and detected an increase in ß~1~-integrin in AD cells \[[@pone.0135157.ref064]\]. After 72 h the protein content of AD cells was comparable to the content of MCS samples, but remained elevated as compared to 1*g*-samples \[[@pone.0135157.ref064]\]. Cellular adhesion and adhesion to the extracellular matrix is very important for the organism and is mediated by integrins. This process occurs early, which might explain why after a 7-day-exposure to s-μg, ß~1~-integrin was reduced in MCS and AD cells. Talin is also required for a normal integrin function and is necessary for the activation of ß~1~-integrins in many cell types. When ML-1 cells were cultured under s-μg, talin was early elevated and MCS exhibited a higher amount of talin compared with 1*g* and AD cells \[[@pone.0135157.ref064]\]. Talin is a cytoskeletal actin-binding protein that binds to integrin and also colocalized with activated integrins. Therefore, an early increase of this protein in parallel to ß~1~-integrin can be expected in microgravity. Afterwards, the cells produce a constant level of this protein on the RPM.

Moreover, we evaluated the proliferation of the cells and measured the amount of Ki-67 protein. Ki-67 is an excellent proliferation marker, which is detectable during the cell cycle phases G1, S, G2, and mitosis, but is absent from resting cells (G0). It indicated a high proliferation in 7-day-old ML-1 and RO82-W-1-cultures, which was higher in AD than in MCS ([Fig 8D and 8H](#pone.0135157.g008){ref-type="fig"}). MCS exhibited an unaltered Ki-67 content compared with corresponding controls ([Fig 8D and 8H](#pone.0135157.g008){ref-type="fig"}). The Ki-67 content was also measured in human endothelial cells \[[@pone.0135157.ref041]\]. In human EAhy926 cells cultured on an RPM, equal amounts of Ki-67 were detectable in adherent cells under both 1*g-* and s-μg-conditions. Ki-67 was reduced by about 50% in MCS floating in the culture medium after 7 days under simulated microgravity \[[@pone.0135157.ref041]\].

In summary, these results support the hypothesis that simulated microgravity using the RPM or the CLINO favors 3D growth of thyroid cancer cells and that IL-6 plays an important role in this process. Il-6 favoring MCS formation and cell aggregation at 1*g* (liquid overlay technique) and simulated microgravity was elevated in simulated microgravity produced on the RPM or CLINO, which is in contrast to experiments in space using the FTC-133 cell line \[[@pone.0135157.ref022]\]. In addition, also IL-8 exerted beneficial effects on spheroid formation under 1g-conditions. This finding has to be investigated in more detail in future s-μg experiments. Cell line-specific differences between ML-1 and RO82-W-1 were found for the release of MCP-1. Therefore, further studies are required to elaborate possible relationships between the differentiation of cancer cells and gravity-dependent changes of cells.

Conclusions {#sec025}
===========

Taken together, the results obtained in this study reveal that experiments with the RPM and the CLINO show similar effects on ML-1 and RO82-W-1 cells with regard to cytokine release and expression of cytoskeletal proteins. Only in 2 out of 14 cytokines released by ML-1 cells and measured by Multianalyte Profiling technology, we found significantly different effects exerted by the CLINO in comparison to the RPM. Hence, the presented results demonstrate a number of common effects of the two devices on the cells. This makes simulation of microgravity on Earth to a valuable method, if one takes in mind that the simulations have to be verified under real microgravity conditions. Experiments in microgravity provide an interesting tool for exploring new targets for cancer therapy. Staying critical and taking side effects into account, ground-based facilities could provide cheaper alternatives of spaceflight research at least for studies on dedicated aspects. The signaling pathways resulting in microgravity-related alterations have to be determined \[[@pone.0135157.ref059]\] in order to identify and separate distinct proteins playing a role in adaption to microgravity and to cancer progression.
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